Dear ICRS Members and ICRS2023 attendees, The ICRS Call for Abstracts for the 33rd Annual International Cannabinoid Research Society's Symposium on the Cannabinoids – ICRS2023 in Toronto, Ontario, Canada – has closed. We look forward to seeing you at our upcoming ICRS Symposium!
This year our 33rd annual ICRS Symposium will be held from June 24 - 29 in Toronto, Canada, at the four-star rated Marriott Toronto Eaton Centre. ICRS2023 is an in-person meeting with options for those delegates who are unable to attend in person to attend virtually. As per ICRS meeting history, short oral and plenary talks will be delivered by delegates attending in-person. At the discretion of the president and the ICRS program committee, a small number of short oral and/or plenary talks may be selected for presentation at the meeting by delegates attending online/virtually, based on quality of abstracts and speaker preferences for in-person versus virtual attendance/presentation. You will be asked to select your preference for in-person versus virtual presentation during the abstract submission process. Attendees will have options to view ICRS presentations virtually, either live or recorded asynchronously. Click here for details and online registration.
Best wishes, Prof. Ruth Ross President International Cannabinoid Research Society
Following this sample abstract as your template, submit your abstract information below:
LIST ALL ABSTRACT AUTHORS – FULL NAMES – NO INITIALS PLEASE – in the same order in which they appear on your abstract. You may add as many authors as you require. PLEASE PLACE AN ASTERISK AFTER THE LAST NAME* OF THE PRESENTING AUTHOR.
>> ADD ONE (1) ABSTRACT AUTHOR << >> REMOVE ONE (1) ABSTRACT AUTHOR <<
1. Data presented at the ICRS2023 Symposium should not have been previously published or presented.
2. If your research involves novel compounds, all structures not previously described must be fully disclosed during your Symposium presentation.
3. Your abstract must be prepared following proper sample abstract formatting. Submitted abstracts should have the following 4 sections: Introduction, Methods, Results and Conclusions. The results section must include a description of the results that will be presented at the conference (and, ideally, actual data and details of statistical analysis). It is not acceptable to write vague statements such as ‘data will be presented in the general area of xxxxxx’. Your abstract should be a concise summary of your study and its results, whether it is intended for presentation in either oral or poster format at the conference.
4. Abstract submissions must be one-page in length, saved in one of the following document formats:
Microsoft Word (.doc,.docx) Mac Pages (.pages) Rich Text (.rtf)
5. If there are figures or tables in your abstract and/or presentation, you must INSERT them into your abstract (Do not drag-and-drop graphics).
6. You must be an ICRS Member-in-Good-Standing to present data at our Symposia, and you must register for the Symposium.
ABSTRACTS NOT REASONABLY FOLLOWING THE FORMAT OF THE ICRS SAMPLE ABSTRACT WILL BE DENIED PEER-REVIEW.
TRAINEE GRANTS are available for qualifying pre- and post-Doctoral trainees presenting data at ICRS2023.
After you complete this abstract submission page, you need to complete the Grant Application and Symposium Registration online by March 20.
Award applicants must: 1) be a pre- or post-Doctoral student/trainee, 2) be an ICRS Trainee Member-in-Good-Standing, 3) be sponsored by an ICRS Member-in-Good-Standing, and 4) have submitted an abstract for review to ICRS2023.
SCIENTIFIC ACHIEVEMENT AWARDS are decided by highest average reviewer scores of Symposium presentations – scored by appointed committee reviewers via secret ballots – and will be presented at the closing ceremonies of the 2023 ICRS Symposium. ONLY pre- and post-Doctoral trainee members are eligible to receive presentation scores/awards. ________________________________________
Please use the list of topics below to characterize your submission. Check all categories that seem appropriate:
Whereas last year's Symposium was fully hybrid, we intend to retain many of the technical aspects of last year's symposium and plan to hold a similar hybrid, live, in-person Symposium in June of 2023 inasmuch as prevailing conditions and best safety practices allow.Delegates unable to physically attend the Symposium in Toronto will have access to all materials, plenaries and oral presentations online – as well as all sponsor materials – via both synchronous and asynchronous technologies.While our intention is for the majority of short oral and plenary talks to be delivered by delegates attending in-person, a small proportion of short oral and plenary talks may be selected for presentation by delegates attending online/virtually, based on quality of abstracts and speaker preferences for in-person versus virtual attendance/presentation. As such, at this time would you prefer:A. To attend and present your work in-person, physically in Toronto - OR -B. To present your work online/virtually because you will NOT attend in-person in Toronto
All ICRS2023 Symposium presentations are going to be either 12-15 minute oral presentations or posters.All novel abstracts submitted will be peer-reviewed by the ICRS Programme Committee. Because there are a finite number of oral berths, abstracts requesting oral presentations that do not make the cut will automatically be reviewed as posters. You do *not* need to submit twice. * All abstracts received after Mar 15 were considered/reviewed only as posters. No abstracts will be accepted for consideration after Mar 20.
Select Your Presentation Preference (Oral, Poster, or No Preference):
THE FOLLOWING MUST BE SUBMITTED WITH YOUR ABSTRACT IN ORDER FOR IT TO BE CONSIDERED FOR PRESENTATION. ABSTRACTS NOT COMPLYING WITH THE INFORMATION YOU'VE SUBMITTED BELOW WILL NOT BE CONSIDERED.
Either
- No conflicts exist (write "none" in the box below), or - A conflict does exist. To the best of my knowledge: (*) (Mandatory) Choose:No conflicts exist.A conflict does exist. (Describe below.) State nature of conflict -or- state "None.": (*) (Mandatory) (1000 chars max) (100 words max) I understand that it is necessary for any conflict to be identified openly at the beginning of my presentation, so that the audience may form their own judgments about the presentation with full disclosure of the facts of my presentation.
(Mandatory) (1000 chars max) (100 words max)
I understand that it is necessary for any conflict to be identified openly at the beginning of my presentation, so that the audience may form their own judgments about the presentation with full disclosure of the facts of my presentation.
START Conference Manager (V2.61.0 - Rev. 7050)